Medication info
Aiprogan Rabeprazole Tablet 10 Milligrams (Rabeprazole Sodium)

Aiprogan Rabeprazole Tablet 10 Milligrams (Rabeprazole Sodium)

Prescription medicationTabletOral
Ingredient · strength
Rabeprazole Sodium›10mg / 1 tablet
Manufacturer / importer
Aiprogan Biologics Co., Ltd.
Appearance
Pale yellow round enteric-coated tablet
Packaging
28 tablets / PTP (28 tablets / PTP x 1)
Approval status
Active

MFDS item code 201500901 · Approved 2015.02.23 · Insurance code 645208630

Summary

Main use
Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome
Who takes it
Adults · Children
Adult dose
Gastric ulcer and duodenal ulcer: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is generally continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition is not cured after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, an on-demand regimen of 10 mg once daily may be used as needed to control subsequent symptoms. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g together twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the needs of each patient. Doses up to 100 mg may be administered once daily, and the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients Use with caution, as hepatic function is often decreased.
Child dose
The safety in children has not been established.

Ingredients

Manufacturer
Aiprogan Biologics Co., Ltd.

Efficacy & effects

Treatment of gastroesophageal reflux disease, peptic ulcers (including eradication therapy), and Zollinger-Ellison syndrome

  • Gastric ulcer
  • duodenal ulcer
  • erosive gastroesophageal reflux disease
  • ulcerative gastroesophageal reflux disease
  • gastroesophageal reflux disease symptoms
  • gastrointestinal ulcers
  • Zollinger-Ellison syndrome
View approved original text

This medication is effective in treating gastric ulcers and duodenal ulcers and alleviating the symptoms of erosive or ulcerative gastroesophageal reflux disease. It is also used for long-term maintenance therapy for gastroesophageal reflux disease and is prescribed in combination with antibiotics for patients with gastrointestinal ulcers infected with Helicobacter pylori. Additionally, it applies to Zollinger-Ellison syndrome to control excessive gastric acid secretion. This drug helps in treating gastric diseases, improving the quality of life for patients.

How to take

Adult dose

Gastric ulcer and duodenal ulcer: The usual adult dose is rabeprazole sodium 10 mg orally once daily. Depending on symptoms, 20 mg may be administered orally once daily. Treatment is generally continued for up to 8 weeks for gastric ulcers and up to 6 weeks for duodenal ulcers. Erosive or ulcerative gastroesophageal reflux disease: Administer 10 mg or 20 mg once daily for 4 ∼ 8 weeks. If the condition is not cured after 8 weeks of treatment with a proton pump inhibitor (PPI, proton pump inhibitor), an additional 8 weeks of oral treatment with 10 mg or 20 mg twice daily may be given. However, 20 mg twice daily is limited to patients with confirmed severe mucosal damage. Relief of symptoms of gastroesophageal reflux disease: Administer 10 mg once daily. If symptoms are not controlled after 4 weeks of treatment, further evaluation is needed. After symptoms resolve, an on-demand regimen of 10 mg once daily may be used as needed to control subsequent symptoms. Long-term maintenance treatment of gastroesophageal reflux disease: Administer 10 mg or 20 mg orally once daily, depending on the patient. Helicobacter pylori eradication: Patients with Helicobacter pylori infection should receive eradication therapy. It is recommended to administer this medicine 20 mg, clarithromycin 500 mg, and amoxicillin 1 g together twice daily for 7 days. Zollinger-Ellison syndrome: The recommended initial dose for adults is 60 mg once daily. The dose may be adjusted up to 120 mg per day according to the needs of each patient. Doses up to 100 mg may be administered once daily, and the 120 mg dose should be divided into 60 mg twice daily. Patients with Zollinger-Ellison syndrome have been treated with this medicine for up to 1 year. Patients with hepatic impairment Adverse reactions of hepatic encephalopathy have been reported in patients with cirrhosis. Therefore, administer with caution. Elderly patients Use with caution, as hepatic function is often decreased.

Child dose

The safety in children has not been established.

Precautions

This medication should not be used by patients who are allergic to certain medications or ingredients. Particularly, those allergic to penicillin or macrolide antibiotics need to exercise caution. Additionally, pregnant or breastfeeding women should avoid taking this medication. Patients with impaired liver function or the elderly should be more cautious when taking the medication, and if any adverse reactions occur, they should immediately consult a doctor. If allergy symptoms such as skin rash, itching, or hives occur while taking this medication, it should be discontinued immediately. Regular blood tests and liver function tests are recommended, and if abnormalities are found, medication should be stopped, and appropriate treatment should be received. Adverse effects can occur in various areas including the heart, digestive system, and nervous system, so any symptoms should be reported to healthcare professionals immediately. Prolonged use may lead to problems such as osteoporosis or hypomagnesemia, so adherence to the prescribed dosage and duration is essential. This medication reduces gastric acid secretion, which may increase the risk of bacterial infection in the stomach; if symptoms like diarrhea persist, healthcare professionals should be informed. It may interact with other medications, so it is crucial to inform healthcare professionals of any medications being taken. Caution is required as drowsiness or dizziness may occur during driving or operating machinery. The tablet should not be chewed or crushed and should be swallowed whole, and it should be kept out of reach of children.

Side effects

Rash, urticaria, itching, erythrocytopenia, leukopenia, leukocytosis, eosinophilia, neutrophilia, lymphocytopenia, anemia, petechiae, lymphadenopathy, hypochromic anemia, pancytopenia, agranulocytosis, thrombocytopenia, hemolytic anemia, elevated ALT, elevated AST, elevated ALP, elevated γ-GTP, elevated LDH, elevated total bilirubin, fulminant hepatitis, liver dysfunction, jaundice, hypertension, myocardial infarction, abnormal electrocardiogram, migraine, syncope, angina, heart block, palpitations, bradycardia, tachycardia, pulmonary embolism, supraventricular tachycardia, thrombophlebitis, vasodilation, prolonged QTc interval, ventricular tachycardia, diarrhea, constipation, abdominal pain, abdominal distension, dyspepsia, belching, nausea, rectal bleeding, bloody stools, anorexia, cholelithiasis, oral ulcer, dysphagia, gingivitis, cholecystitis, increased appetite, abnormal stools, colitis, esophagitis, glossitis, pancreatitis, proctitis, thirst, vomiting, lower abdominal pain, gastric body, gastritis, stomatitis, altered taste, hemorrhagic diarrhea, cholangitis, duodenitis, gastrointestinal bleeding, hepatic encephalopathy, hepatitis, liver cancer, hepatic steatosis, salivary gland enlargement, thirst, headache, insomnia, anxiety, dizziness, seizures, abnormal dreams, decreased libido, neuropathy, sensory abnormalities, tremor, weakness, neural hyperexcitability, drowsiness, vertigo, depression, agitation, amnesia, confusion, extrapyramidal syndrome, increased circulating blood volume, limb flaccidity, sensory impairment, decreased grip strength, language confusion, staggering, delirium, disorientation, sleepiness, cough, pharyngitis, rhinitis, dyspnea, asthma, epistaxis, laryngitis, hiccups, hyperventilation, bronchitis, sinusitis, apnea, respiratory depression, interstitial pneumonia, myalgia, low back pain, arthritis, leg cramps, bone pain, arthrosis, bursitis, muscular hypertonicity, neuralgia, single contraction, sweating, alopecia, skin dryness, shingles, psoriasis, skin color changes, toxic epidermal necrolysis, mucocutaneous syndrome, erythema multiforme, cataract, amblyopia, glaucoma, dry eyes, abnormal vision, tinnitus, otitis media, corneal opacity, blur, diplopia, hearing loss, eye pain, retinal degeneration, strabismus, proteinuria, cystitis, pollakiuria, dysmenorrhea, urinary difficulties, nephrolithiasis, uterine bleeding, polyuria, breast enlargement, hematuria, erectile dysfunction, vaginal discharge, menorrhagia, epididymitis, incontinence, interstitial nephritis, edema, elevated total cholesterol, elevated triglycerides, elevated BUN, elevated serum thyroid-stimulating hormone, chest pain, chills, fever, urinary tract infection, erythema, fatigue, weight gain, visual disturbances, anorexia, neck stiffness, phototoxic reaction, hangover effect, weight loss, gout, anaphylaxis, shock, hepatitis, jaundice, hepatic encephalopathy, sudden death, coma, hyperammonemia, rhabdomyolysis, delirium, angioedema, hypomagnesemia, thrombocytopenia, neutropenia, agranulocytosis, hemolytic anemia, pancytopenia, vesicular skin rash, urticarial skin rash, systemic allergic reaction, myalgia, arthralgia, interstitial nephritis, gynecomastia, elevated thyroid-stimulating hormone, erythema multiforme, toxic epidermal necrolysis, mucocutaneous syndrome, increased INR, prolonged prothrombin time, bone fracture, Clostridium difficile-associated diarrhea, systemic lupus erythematosus, skin lupus erythematosus

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent exposure to air or moisture, and it is safe to store at room temperature between 1 to 30 degrees Celsius.

Appearance and packaging

Appearance

Pale yellow round enteric-coated tablet

Package unit

28 tablets / PTP (28 tablets / PTP x 1)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.